News

April 22, 2021

BioSkryb Appoints Sean Keohane Senior Vice President of Commercial Operations

DURHAM, N.C.–(BUSINESS WIRE)–BioSkryb, Inc., today announced the expansion of the company’s leadership team with the appointment of Sean Keohane as Senior Vice President of Commercial Operations. Keohane has more than 25 years of experience in life science product commercialization, with demonstrated success in building strong teams and implementing strategic...

March 10, 2021

Top 10 BioTech Industry Trends & Innovations in 2021

The BioTech industry is adopting trends like artificial intelligence (AI), data analytics, and automation to optimize production. Consequently, there has been a rise in consumer BioTech or BioTech products targeted directly at customers instead of biopharma or healthcare businesses. While the industry largely still focuses on medicine, startups are...

March 2, 2021

BioSkryb Announces the Winners of Its Grant Program to Aid Research Using Primary Template-directed Amplification Technology

DURHAM, N.C.–(BUSINESS WIRE)–Today, at the Advances in Genome Biology and Technology (AGBT) 2021 General Meeting held virtually, BioSkryb, Inc., a developer of genomic amplification technologies, announced the winners of a research grant program sponsored by the company. The grant program was created to accelerate innovation of single-cell genomic studies using...

December 10, 2020

BioSkryb Announces Research Grants to Access Breakthrough Single-Cell Whole Genome Amplification Technologies

DURHAM, N.C.–(BUSINESS WIRE)–BioSkryb, Inc., a developer of genomic amplification technologies, today announced the launch of a research grant program sponsored by the company to accelerate innovation of single-cell genomic studies using its primary template-directed amplification (PTA) technology, now commercially available as the ResolveDNA™ suite of products. The program will...

December 1, 2020

BioSkryb Announces First Data Demonstrating Novel PTA Technology Improves Accuracy in Whole Genome Amplification for Single Cell Analyses

December 01, 2020 08:00 AM EST DURHAM, N.C.–(BUSINESS WIRE)–BioSkryb, Inc., a developer of genomic amplification technologies, today reported the release of foundational data before publication on the preprint server, bioRxiv, demonstrating the superior ability of primary template-directed amplification (PTA) to accurately and uniformly amplify the genomes of single cells....

October 27, 2020

BioSkryb’s Novel PTA Technology for High-Quality Single-Cell Whole Genome Amplification Will Be Commercially Available for the First Time at ASHG 2020

Research being presented at ASHG 2020 to support use of PTA technology in the study of genetic variants that contribute to drug resistance in cancer treatment October 26, 2020 09:00 AM Eastern Daylight Time DURHAM, N.C.–(BUSINESS WIRE)–BioSkryb, Inc., a developer of genomic amplification technologies, today announced the commercial launch...

August 3, 2020

BioSkryb Launches Researcher Early Access Program for Genomic Amplification Technology

DURHAM, NC, Aug. 3, 2020 — BioSkryb, Inc. (“BioSkryb”), a developer of genomic amplification technologies that deliver higher coverage and fidelity for gene sequencing, today announced that it has launched an Early Access Program (EAP) for researchers to test its proprietary genomic amplification technology (Primary Template-directed Amplification or PTA)....

June 22, 2020

BioSkryb and St. Jude Children’s Research Hospital Partner

Single Cell Genome Sequencing Company BioSkryb and St. Jude Children’s Research Hospital Partner to Develop Clinical Diagnostic Solutions to Identify Resistant Cancer Cells as Patients Undergo Treatment DURHAM, N.C., June 22, 2020 /PRNewswire/ — BioSkryb, a developer of genomic amplification technologies that deliver higher coverage and fidelity for gene...

April 21, 2020

Addressing Coronavirus Testing Bottleneck, Scientists Turn to RNA-Extraction-Free PCR

Apr 20, 2020 | Julia Karow NEW YORK – Two months into the COVID-19 pandemic, the number of SARS-CoV-2 molecular diagnostic tests across the US remains woefully inadequate. According to the COVID Tracking Project, a volunteer effort to track testing across the country headed by The Atlantic, more than...

April 14, 2020

The Genesis of Genotypes

Tuesday, April 14, 2020 | Mike May Delving into a single cell’s DNA reveals a reductionist’s dream. By unraveling the identity and order of nucleic acids in just one cell, scientists can explore some of the most basic biology, and clinicians can better understand and treat more diseases. With...